Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsVivimedlabs

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Bull's Eye: Buy Jet Airways, L&T Finance, NIIT Tech, Strides Shasun, Indiabulls Real Estate

      Vishal Malkan of malkansview.com recommends buying L&T Finance Holdings with a stoploss at Rs 165 and target of Rs 185 and a buy also on Tata Motors DVR with a stoploss at Rs 225 and target of Rs 245.

    • Bull's Eye: Buy Delta Corp, IRB Infra, Bata, Jet Airways, DHFL; Sell Exide

      Vishal Malkan of malkansview.com advises buying Bata India with a target of Rs 765.

    • Buy Reliance Industries, Indraprastha Gas, HDFC Bank, Avanti Feeds: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Reliance Industries, Indraprastha Gas, HDFC Bank and Avanti Feeds.

    • Bull's Eye: Buy Wockhardt, KPIT Tech, NMDC; sell JSW Energy, Apollo Tyres

      Vijay Chopra of enochventures.com is of the view that one may buy NMDC with a target of Rs 130.

    • Bull's Eye: Buy Tata Motors, Godrej Properties, Nucleus Software; sell Adani Enterprises

      Vijay Chopra of enochventures.com advices buying Oil India with a target of Rs 335.

    • Ashish Kacholia: This multibagger smallcap picker has 19 stock ideas to win big

      The approach of investing towards small to midcap in a scenario where the market is trading at record highs should be based on core fundamentals and not momentum in the stocks.

    • Here are SP Tulsian's top trading picks

      In an interview to CNBC-TV18's Surabhi Upadhyay and Reema Tendulkar, SP Tulsian shared his outlook and readings on the fundamentals of the market and specific stocks.

    • Thomas Cook showing signs of improvement: Deven Choksey

      In an interview to CNBC-TV18, Deven Choksey, MD of KRChoksey Investment Managers shared his readings and outlook on specific stocks that came out with good quarterly numbers.

    • Tulsian's take on ICICI Pru Life listing, MRF & other tyre shrs

      SP Tulsian of sptulsian.com tells CNBC-TV18 why he would not give a buy call on MRF stock which touched Rs 50,000-mark in trade Wednesday. He also shares his take on other tyre stocks.

    • Here are a few investment ideas from SP Tulsian

      In an interview to CNBC-TV18's Latha Venkatesh and Anuj Singhal, SP Tulsian of sptulsian.com shared his readings and outlook on specific stocks and sectors.

    • Here are a few stocks to keep an eye on September 28

      Here are a few stocks picked up by CNBC-TV18's analysts to focus today - stocks expected to gain are IGL, Vivimed Labs, Balaji Telefilms, ARSS infra, Motherson Sumi, Aurobindo Pharma, MPhasis and Tata Global Beverages while stocks expected to be under pressure are REC, Manpasand Beverages, Ahluwalia Contracts and Bajaj Finserv.

    • Vivimed Labs may test Rs 500 in 6 months, says SP Tulsian

      SP Tulsian of sptulsian.com is of the view that Vivimed Labs may test Rs 500 in next six months.

    • Short Jindal Steel; buy Lupin, Vivimed Labs: Pankaj Jain

      Pankaj Jain of Sunteck Wealthmax recommends going long in Vivimed Labs and Lupin.

    • Bull's Eye: Buy Lupin, HDFC; short HDIL, Reliance Capital

      Meghana V Malkan, malkansview.com advises buying Ranbaxy Labs for a target price of Rs 615 and selling Reliance Capital for a target price of Rs 495.

    • Buy GSFC, Onmobile Global, Vivimed Labs: Pankaj Jain

      Pankaj Jain of Sunteck Wealthmax recommends buying DCB Bank and Vivimed Labs.

    • Bull's Eye: Buy DCB Bank, Eros International, CESC, UPL

      AK Prabhakar, Independent Advisor advises buying Eros International for a target price of Rs 300 and Bank of India for a target price of Rs 319.

    • Buy Vivimed Labs, Pennar Ind; short JP Asso: Pankaj Jain

      Pankaj Jain of Sunteck Wealthmax recommends selling Indiabulls Real Estate and Jaiprakash Associates.

    • Bull's Eye: Buy Vivimed Labs, Tata Coffee, Exide Industries

      Pankaj Jain, Sunteck Wealthmax advises buying Vivimed Labs for a target price of Rs 375 and Pennar Industries for a target price of Rs 63.

    • Vivimed Labs may touch Rs 600: Sudip Bandyopadhyay

      Vivimed Labs may touch Rs 600, says Sudip Bandyopadhyay, MD & CEO, Destimoney Securities.

    • Bull's Eye: Buy Rel Power, Sun TV; short Crompton Greaves

      Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

    • Buy Vivimed Labs above Rs 260: Shardul Kulkarni

      Buy Vivimed Labs above Rs 260, says Shardul Kulkarni of Angel Broking.

    • Buy Vivimed Labs: Ashish Chugh

      Investment advisor Ashish Chugh feels that one should buy Vivimed Labs.

    • Vivimed Labs has target of Rs 400: SP Tulsian

      Vivimed Labs has target of Rs 400, says SP Tulsian of sptulsian.com.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347